Pyridoxal isonicotinoyl hydrazone and its analogues.
Buss
Joan L
JL
Lady Davis Institute for Medical Research, Sir Mortimer B. Davis Jewish General Hospital and Department of Physiology, McGill University, Montreal, Quebec, Canada.
Hermes-Lima
Marcelo
M
Ponka
Prem
P
D000818:Animals; D000975:Antioxidants / Q000737:chemistry / Q000494:pharmacology; D004353:Drug Evaluation, Preclinical; D006801:Humans; D066298:In Vitro Techniques; D007501:Iron / Q000378:metabolism; D007502:Iron Chelating Agents / Q000737:chemistry / Q000494:pharmacology* / Q000633:toxicity; D019190:Iron Overload / Q000188:drug therapy / Q000378:metabolism; D007538:Isoniazid / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000494:pharmacology* / Q000633:toxicity; D015394:Molecular Structure; D011730:Pyridoxal / Q000031:analogs & derivatives* / Q000737:chemistry* / Q000494:pharmacology* / Q000633:toxicity
D000975:Antioxidants; D007502:Iron Chelating Agents; D011730:Pyridoxal; C021079:pyridoxal isonicotinoyl hydrazone; D007501:Iron; D007538:Isoniazid